Shirley Reynolds

Profile photo of Shirley Reynolds
Shirley Reynolds is Director of the Charlie Waller Institute and Professor of Evidence Based Psychological Therapies at the University of Reading. Her research interests focus around understanding and treating depression and anxiety disorders in children and adolescents. She was founding co-editor of Evidence Based Mental Health and past President of the British Association of Behavioural and Cognitive Psychotherapy (BABCP: 2010-2012). Shirley has worked on a number of RCTs of psychological and social interventions for anxiety, OCD and depression funded by MRC/ESRC and the NIHR. She is involved in a number of national programmes including the MindEd e-learning programme (www.minded.org.uk) and the Child and Young People Increasing Access to Psychological Therapies (CYP IAPT) programme.

Website

Follow me here –

Cyberbullying: comparatively rare, not especially damaging or pernicious

student-1397451_1280

Shirley Reynolds reports on a recent population-based cross-sectional study that surveyed 1 in 5 of all 15 year olds in England, to ask them about bullying, cyberbullying and adolescent well-being.

[read the full story...]

Which psychotherapies are best for college students with depression?

8548057127_64281ee69f_z

Shirley Reynolds laments the lack of recent high quality evidence, as she reviews a recent meta-analysis of psychological treatment of depression in college students.

[read the full story...]

Psychotherapies for depression in children and young people

shutterstock_265981373

Shirley Reynolds considers the findings of a recent network meta-analysis, which investigates the comparative efficacy and acceptability of psychotherapies for depression in children and adolescents.

[read the full story...]

Cognitive bias modification for anxiety and depression in children and adolescents

shutterstock_97786961

Shirley Reynolds writes her debut Mental Elf blog on a recent meta-analysis of cognitive bias modification (CBM) for anxiety and depression in children and adolescents. The review suggests that, on the face of it, we should not be investing in future CBM research, but is it that simple?

[read the full story...]